Financial impact of adult living donation

被引:12
作者
Russo, MW
Brown, RS
机构
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
D O I
10.1053/jlts.2003.50228
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Key Points 1. Cost analyses of living-donor liver transplantation (LDLT) and deceased-donor liver transplantation should capture costs incurred during the pretransplantation time period because benefits of LDLT likely result from reducing complications and cost pretransplantation. 2. Cost analyses should capture the costs associated with donor evaluation in LDLT since these costs are specific to LDLT and not associated with deceased-donor liver transplantation. 3. Indirect costs, such as time lost from work for donor and recipient, are difficult to estimate and frequently are not incorporated in cost-effectiveness analyses. However, they are important, particularly from a societal perspective.
引用
收藏
页码:S12 / S15
页数:4
相关论文
共 26 条
[1]   Trends in expenditures for medicare liver transplant recipients [J].
Best, JH ;
Veenstra, DL ;
Geppert, J .
LIVER TRANSPLANTATION, 2001, 7 (10) :858-862
[2]  
Brown RS, 1997, ARCH SURG-CHICAGO, V132, P1098
[3]   Predictors of the cost of liver transplantation [J].
Brown, RS ;
Lake, JR ;
Ascher, NL ;
Emond, JC ;
Roberts, JP .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (02) :170-176
[4]   A survey of liver transplantation from living adult donors in the United States [J].
Brown, RS ;
Russo, MW ;
Lai, M ;
Shiffman, ML ;
Richardson, MC ;
Everhart, JE ;
Hoofnagle, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :818-825
[5]   Cost-effectiveness of different strategies of cytomegalovirus prophylaxis in orthotopic liver transplant recipients [J].
Das, A .
HEPATOLOGY, 2000, 31 (02) :311-317
[6]  
EVANS RW, 1993, GASTROENTEROL CLIN N, V22, P451
[7]   An economic analysis of kidney transplantation [J].
Evans, RW ;
Kitzmann, DJ .
SURGICAL CLINICS OF NORTH AMERICA, 1998, 78 (01) :149-+
[8]   Cost-effective and safe ambulatory long-term immunoprophylaxis with intramuscular instead of intravenous hepatitis B immunoglobulin to prevent reinfection after orthotopic liver transplantation [J].
Faust, D ;
Rabenau, HF ;
Allwinn, R ;
Caspary, WF ;
Zeuzem, S .
CLINICAL TRANSPLANTATION, 2003, 17 (03) :254-258
[9]   Evolving trends in liver transplantation - An outcome and charge analysis [J].
Gilbert, JR ;
Pascual, M ;
Schoenfeld, DA ;
Rubin, RH ;
Delmonico, FL ;
Cosimi, AB .
TRANSPLANTATION, 1999, 67 (02) :246-253
[10]  
Jacobs C, 1998, Adv Ren Replace Ther, V5, P89